Stockreport
Veracyte's (VCYT) CEO Bonnie Anderson on Q1 2017 Results - Earnings Call Transcript [Seeking Alpha]
Last veracyte earnings: 2/27 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF
Veracyte, Inc. (NASDAQ: VCYT ) Q1 2017 Results Earnings Conference Call May 3, 2017, 04:30 PM ET Executives Bonnie Anderson - Chief Executive Officer and Chairman of the Board Keith Kennedy - Chief Financial Officer Christopher Hall - President and Chief Operating Officer Analysts Puneet Souda - LEERINK Partners LLC Amanda Murphy - William Blair & Company, LLC Alexander Nowak - Piper Jaffray & Co. Bryan Brokmeier - Cantor Fitzgerald Carolina Ibanez-Ventoso - Janney Montgomery Scott LLC Operator Good afternoon, ladies and gentlemen, and welcome to the Veracyte first quarter 2017 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that. [Operator Instructions]. As a reminder, this conference call is being recorded. I’d now like to turn the conference over to your host, Ms. Bonnie Anderson, Chief Executive Officer and Chairman
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VCYT | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VCYT alerts
VCYT alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting VERACYTE news events
Weekly update
A roundup of the hottest topics
VCYT
NEWS
NEWS
- Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on Tuesday, May 1, 2018[Business Wire]
- Veracyte (NASDAQ: VCYT) was given a new $13.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.[MarketBeat]
- Nephros announces $2.9M private placement [Seeking Alpha][Seeking Alpha]
- Loxo teams up with Veracyte to advance development of therapies for genetically defined cancers [Seeking Alpha][Seeking Alpha]
- BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology [Reuters][Reuters]
- More
VCYT
SEC Filings
SEC Filings
- 4/19/18 - Form DEFA14A
- 4/19/18 - Form DEF
- 3/5/18 - Form 4
- VCYT's page on the SEC website
- More